Tvardi Therapeutics Inc. Com

13F holders, Q4 2024 (December 31)
42holders +41
7new positions
0sold out
2famous investors
$6.12avg. 13F price*

At the end of Q4 2024, 42 institutions reported holding Tvardi Therapeutics Inc. Com in their 13F filings, up 41 from Q3 2024. 7 opened new positions and 0 sold out. The largest holders were Vanguard Group Inc. ($1.0M), Rockefeller Capital Management L.P. ($953K) and Farallon Capital Management, L.L.C. ($794K). 2 famous investors held it, including Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio) and Israel Englander (0.0% of Millennium Management's portfolio).

Company
Tvardi Therapeutics Inc. Com
Filed as
CARA THERAPEUTICS INC (Q4 2024)
CUSIP
140755208
Latest filing quarter
Q4 2025

History

Number of 13F holders

01020304050 Q3 2024: 1Q3 2024Q4 2024: 42Q4 2024Q1 2025: 35Q1 2025Q2 2025: 7Q2 2025Q3 2025: 8Q3 2025Q4 2025: 3Q4 2025

Total Exit/New Position Q3 2024 → Q4 2024

InstitutionsTotal Value
New Positions7$1.8M
Exits0$0

All 13F filers, Q3 2024 → Q4 2024: 406,509 shares bought and 103,092 shares sold, net +303,417 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.

Ownership 42 holders

Vanguard Group Inc. 0.00% Reduce -10.3% 168,101 $1.0M
Rockefeller Capital Management L.P. 0.00% New 155,717 $953K
Farallon Capital Management, L.L.C. 0.00% No change 129,685 $794K
Susquehanna International Group, LLP 0.00% Add +1008.5% 117,785 $721K
Renaissance Technologies 0.00% Add +1.8% 94,030 $575K
Shay Capital LLC 0.13% New 85,692 $524K
Two Sigma Advisers, LP 0.00% Reduce -11.1% 64,180 $393K
BlackRock, Inc. 0.00% No change 61,869 $379K
Curi Capital, LLC 0.01% New 45,333 $277K
Millennium Management 0.00% Reduce -19.5% 39,441 $241K
Geode Capital Management, LLC 0.00% No change 37,684 $231K
FMR LLC 0.00% Add +10.8% 19,405 $119K
State Street Corp. 0.00% Reduce -0.9% 14,889 $91K
BNP Paribas Financial Markets 0.00% Reduce -72.4% 13,372 $82K
LPL Financial LLC 0.00% Reduce -1.6% 12,218 $75K
UBS Group AG 0.00% Add +5082.8% 8,082 $49K
Citigroup Inc. 0.00% No change 1,924 $12K
JPMorgan Chase & Co. 0.00% Add +216.1% 1,383 $8K
Morgan Stanley 0.00% Reduce -3.3% 1,302 $8K
Acadian Asset Management LLC 0.00% Reduce -77.8% 842 $5K
Arax Advisory Partners 0.00% Reduce -3.9% 606 $4K
Bank of America Corp. 0.00% Reduce -98.5% 419 $3K
Tower Research Capital LLC (TRC) 0.00% Reduce -13.4% 382 $2K
LRI Investments, LLC 0.00% Reduce -0.4% 249 $2K
Osaic Holdings, Inc. 0.00% Reduce -85.0% 118 $719
NewEdge Advisors, LLC 0.00% No change 97 $594
Wells Fargo & Company 0.00% Reduce -10.5% 81 $496
McIlrath & Eck, LLC 0.00% Reduce -0.5% 61 $375
Group One Trading LLC 0.00% Reduce -23.6% 54 $330
Allworth Financial LP 0.00% Reduce -1.5% 59 $283
MAI Capital Management 0.00% New 30 $184
Truvestments Capital LLC 0.00% Add +56.9% 23 $141
SBI Securities Co., Ltd. 0.00% — 21 $129
Painted Porch Advisors LLC 0.00% Reduce -92.0% 20 $122
Jones Financial Companies LLLP 0.00% New 19 $116
Creative Financial Designs Inc. 0.00% Reduce -1.8% 18 $110
Front Row Advisors LLC 0.00% Reduce -10.0% 6 $37
Comerica Bank 0.00% Reduce -10.0% 3 $20
Cornerstone Planning Group LLC 0.00% Reduce -10.0% 3 $16
Danske Bank A/S 0.00% New 2 $12
Royal Bank of Canada 0.00% Add +68.4% 63 $0
Simplex Trading, LLC 0.00% Add +424.0% 134 $0

"% of holder's portfolio" is TVARDI THERAPEUTICS INC COM's weight in each manager's 13F, not the share of Tvardi Therapeutics Inc. Com the manager owns.